| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |